We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > mycophenolate mofetil

News List

Par Pharmaceutical Issues Recall of One Lot of Mycophenolate Mofetil for Injection americanpharmaceuticalreview
May 08, 2019
Endo International announced one of its operating companies, Par Pharmaceutical, is voluntarily recalling one lot of Mycophenolate Mofetil for Injection, USP to the hospital and retail pharmacy level.
Majority of HIV persistence during ART due to infected cell proliferation: Study confirms biological mechanism responsible for latent HIV reservoirs; suggests strategies for a functional HIV cure firstwordpharma
November 19, 2018
According to study findings published in Nature Communications, a majority of the HIV-infected cells that persist in HIV-infected patients even during suppressive